A randomized clinical trial on the treatment of oral herpes with topical zinc oxide/glycine - PubMed (original) (raw)
Clinical Trial
. 2001 May-Jun;7(3):49-56.
Affiliations
- PMID: 11347285
Clinical Trial
A randomized clinical trial on the treatment of oral herpes with topical zinc oxide/glycine
H R Godfrey et al. Altern Ther Health Med. 2001 May-Jun.
Abstract
Context: A zinc preparation that provides a higher concentration of solubilized zinc in a minimally irritating formulation allowing controlled absorption would be of great clinical value for treating oral herpes.
Objective: To determine the effect of zinc oxide/glycine cream as a treatment for facial and circumoral herpes infection by measuring duration and intensity of signs and symptoms and assessing adverse effects.
Design: Double-blind, placebo-controlled, randomized clinical trial.
Setting: Subjects were enrolled from the general community through advertisements.
Patients: Forty-six subjects with facial or circumoral herpes infections.
Intervention: Application of a zinc oxide/glycine cream or a placebo cream every 2 hours until cold sore resolved or 21 days elapsed.
Main outcome measures: Duration of cold sore lesions, severity of signs and symptoms, and frequency of adverse effects.
Results: Subjects who began treatment with a zinc oxide/glycine cream within 24 hours of onset of signs and symptoms experienced a significantly shorter duration of cold sore lesions (mean, 5.0 days) than did subjects treated with a placebo cream (mean, 6.5 days). Subjects treated with the zinc oxide/glycine cream also experienced reduction in overall severity of signs and symptoms, particularly blistering, soreness, itching, and tingling. Side effects among subjects treated with zinc oxide/glycine cream were those expected from an ionic zinc salt solution. All were completely reversible and of short duration.
Conclusion: Zinc oxide/glycine cream is an effective treatment for facial and circumoral herpes infection with predictable adverse effects that are completely reversible.
Similar articles
- Treatment and prevention of herpes labialis.
Opstelten W, Neven AK, Eekhof J. Opstelten W, et al. Can Fam Physician. 2008 Dec;54(12):1683-7. Can Fam Physician. 2008. PMID: 19074705 Free PMC article. Review. - Can clinical trials requiring frequent participant contact be conducted over the Internet? Results from an online randomized controlled trial evaluating a topical ointment for herpes labialis.
Formica M, Kabbara K, Clark R, McAlindon T. Formica M, et al. J Med Internet Res. 2004 Feb 17;6(1):e6. doi: 10.2196/jmir.6.1.e6. J Med Internet Res. 2004. PMID: 15111272 Free PMC article. Clinical Trial. - Topical application of penciclovir cream for the treatment of herpes simplex facialis/labialis: a randomized, double-blind, multicentre, aciclovir-controlled trial.
Lin L, Chen XS, Cui PG, Wang JB, Guo ZP, Lu NZ, Bi ZG, Jia H, Yang XY; Topical Penciclovir Clinical Study Group. Lin L, et al. J Dermatolog Treat. 2002 Jun;13(2):67-72. doi: 10.1080/095466302317584412. J Dermatolog Treat. 2002. PMID: 12060504 Clinical Trial. - Clinical efficacy of topical docosanol 10% cream for herpes simplex labialis: A multicenter, randomized, placebo-controlled trial.
Sacks SL, Thisted RA, Jones TM, Barbarash RA, Mikolich DJ, Ruoff GE, Jorizzo JL, Gunnill LB, Katz DH, Khalil MH, Morrow PR, Yakatan GJ, Pope LE, Berg JE; Docosanol 10% Cream Study Group. Sacks SL, et al. J Am Acad Dermatol. 2001 Aug;45(2):222-30. doi: 10.1067/mjd.2001.116215. J Am Acad Dermatol. 2001. PMID: 11464183 Clinical Trial. - Zinc gluconate and the common cold. Review of randomized controlled trials.
Marshall S. Marshall S. Can Fam Physician. 1998 May;44:1037-42. Can Fam Physician. 1998. PMID: 9612589 Free PMC article. Review.
Cited by
- A series of in vitro and human studies of a novel lip cream formulation for protecting against environmental triggers of recurrent herpes labialis.
Gfeller CF, Wanser R, Mahalingam H, Moore DJ, Wang X, Lin CB, Shanga G, Grove G, Rawlings AV. Gfeller CF, et al. Clin Cosmet Investig Dermatol. 2019 Mar 22;12:193-208. doi: 10.2147/CCID.S179430. eCollection 2019. Clin Cosmet Investig Dermatol. 2019. PMID: 30962701 Free PMC article. - Comparative study of serum zinc concentration in recurrent herpes labialis patients and healthy individuals.
Ranjbar Z, Zahed M, Ranjbar MA, Shirmardan Z. Ranjbar Z, et al. BMC Oral Health. 2020 Oct 28;20(1):296. doi: 10.1186/s12903-020-01277-2. BMC Oral Health. 2020. PMID: 33115470 Free PMC article. - Instantaneous Inactivation of Herpes Simplex Virus by Silicon Nitride Bioceramics.
Pezzotti G, Ohgitani E, Ikegami S, Shin-Ya M, Adachi T, Yamamoto T, Kanamura N, Marin E, Zhu W, Okuma K, Mazda O. Pezzotti G, et al. Int J Mol Sci. 2023 Aug 10;24(16):12657. doi: 10.3390/ijms241612657. Int J Mol Sci. 2023. PMID: 37628838 Free PMC article. - Current Antivirals and Novel Botanical Molecules Interfering With Herpes Simplex Virus Infection.
Álvarez DM, Castillo E, Duarte LF, Arriagada J, Corrales N, Farías MA, Henríquez A, Agurto-Muñoz C, González PA. Álvarez DM, et al. Front Microbiol. 2020 Feb 11;11:139. doi: 10.3389/fmicb.2020.00139. eCollection 2020. Front Microbiol. 2020. PMID: 32117158 Free PMC article. Review. - Treatment and prevention of herpes labialis.
Opstelten W, Neven AK, Eekhof J. Opstelten W, et al. Can Fam Physician. 2008 Dec;54(12):1683-7. Can Fam Physician. 2008. PMID: 19074705 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical